org placeholder image

Vassiliki Karantza

Individualized Neoantigen Therapy (Int)-V940 Asset Lead at Merck

  • LinkedIn

Email Email: v****@merck.com

phone noPhone Number: (***)-***-****

map
MERCK

MERCK

  • Employees count Employees 10001+
  • Revenue Revenue 1 Billion and Over
signout-image
You are signed out

Sign in to CIENCE GO Data to uncover contact details

crown-icon Free credits every month

Merck Org Chart and Mapping

Employees

Shrishti Kedia

Quality Assurance Specialist

Emily Walczyk

Digital Health & Innovative Alliances Senior Specialist

Xiaoli Ping

Senior Research Scientist

Kenneth Simon

Associate Director, Vaccine Sales

Lisa Guarino

Senior Sales Representative- Oncology Division

Shariefah Bratcher

E-Learning Program and Course Development

Frequently Asked Questions Regarding Vassiliki Karantza

Answer: Vassiliki Karantza works for Merck as Individualized Neoantigen Therapy (Int)-V940 Asset Lead

Answer: Vassiliki Karantza’s role in Merck is Individualized Neoantigen Therapy (Int)-V940 Asset Lead

Answer: Vassiliki Karantza's email address is v***@gmail.com

Answer: Vassiliki Karantza's business email address is v****@merck.com

Answer: Vassiliki Karantza’s direct phone number is (***)-***-****

Answer: Vassiliki Karantza works in the industry of: Pharmaceuticals

Answer: Vassiliki Karantza works Merck located at 126 E Lincoln Ave, Rahway, New Jersey, 07065, United States

Answer: Merck's Individualized Neoantigen Therapy (Int)-V940 Asset Lead is Vassiliki Karantza

Answer: Vassiliki Karantza contact details:

  • Phone number  :  (***)-***-****
  • Email  :  v****@merck.com

Premium Sales Data for Prospecting

  • Sales data across over 200M records

  • Up-to-date records (less decayed data)

  • Accurate Email Lists (real-world tested)

  • Powerful search engine and intuitive interface

lock icon Get Full Access